Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer.
Biochem Pharmacol
; 210: 115459, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36813121
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triple Negative Breast Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Biochem Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: